Login to Your Account

American Society of Hematology 2013

ASH Abstracts Release Has Geron Buyers Proliferating

By Anette Breindl
Science Editor

Friday, November 8, 2013
Abstracts of the data that are to be presented at the American Society of Hematology’s annual meeting next month were released Thursday. And the biggest market response to trial data involved Geron Corp’s myelofibrosis drug Imetelstat.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription